https://www.selleckchem.com/pr....oducts/cbl0137-cbl-0
28, 95% CI 1.97-2.64). In RCTs of low-dose aspirin, we observed strong evidence for lower risk of CVD in people without CVD (RR = 0.83; 95% CI 0.79-0.87) and in general population (RR = 0.83; 95% CI 0.79-0.89), higher risk of major gastrointestinal (RR = 1.47; 95% CI 1.26-1.72) and intracranial bleeding (RR = 1.34; 95% CI 1.18-1.53), and of major bleedings in people without CVD (RR = 1.62; 95% CI 1.26-2.08). Conclusion Compared to other active medications, low-dose aspirin had strong evidence for lower risk of bleeding, but als
Like
Comment
Share
